Raymond James & Associates’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-8,046
| Closed | -$635K | – | 3945 |
|
|
2020
Q4 | $635K | Buy |
8,046
+2,780
| +53% | +$219K | ﹤0.01% | 2636 |
|
|
2020
Q3 | $231K | Buy |
+5,266
| New | +$231K | ﹤0.01% | 3093 |
|
|
2020
Q2 | – | Sell |
-46,005
| Closed | -$1.65M | – | 3557 |
|
|
2020
Q1 | $1.65M | Buy |
46,005
+13,230
| +40% | +$475K | ﹤0.01% | 1683 |
|
|
2019
Q4 | $2.32M | Buy |
32,775
+24,217
| +283% | +$1.72M | ﹤0.01% | 1737 |
|
|
2019
Q3 | $640K | Buy |
8,558
+4,707
| +122% | +$352K | ﹤0.01% | 2484 |
|
|
2019
Q2 | $311K | Buy |
3,851
+486
| +14% | +$39.2K | ﹤0.01% | 2978 |
|
|
2019
Q1 | $225K | Buy |
3,365
+228
| +7% | +$15.2K | ﹤0.01% | 3150 |
|
|
2018
Q4 | $234K | Sell |
3,137
-487
| -13% | -$36.3K | ﹤0.01% | 3008 |
|
|
2018
Q3 | $334K | Sell |
3,624
-1,006
| -22% | -$92.7K | ﹤0.01% | 2946 |
|
|
2018
Q2 | $455K | Buy |
4,630
+1,192
| +35% | +$117K | ﹤0.01% | 2740 |
|
|
2018
Q1 | $383K | Buy |
3,438
+466
| +16% | +$51.9K | ﹤0.01% | 2726 |
|
|
2017
Q4 | $306K | Buy |
2,972
+381
| +15% | +$39.2K | ﹤0.01% | 2808 |
|
|
2017
Q3 | $244K | Buy |
+2,591
| New | +$244K | ﹤0.01% | 2902 |
|
|
2016
Q3 | – | Sell |
-2,962
| Closed | -$204K | – | 3165 |
|
|
2016
Q2 | $204K | Sell |
2,962
-592
| -17% | -$40.8K | ﹤0.01% | 2637 |
|
|
2016
Q1 | $254K | Buy |
+3,554
| New | +$254K | ﹤0.01% | 2438 |
|
|
2015
Q2 | – | Sell |
-23,919
| Closed | -$1.14M | – | 2462 |
|
|
2015
Q1 | $1.14M | Sell |
23,919
-2,676
| -10% | -$127K | 0.01% | 1585 |
|
|
2014
Q4 | $1.15M | Buy |
+26,595
| New | +$1.15M | 0.01% | 1485 |
|